Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
UCB Pharma GmbH
The purpose of this study is to assess the clinical efficacy of Cimzia in achieving clinical remission after two years of therapy. The observational nature of the study leaves the therapeutic decision exclusively within the discretion of the treating physician.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patients eligible for treatment with Cimzia as defined in EU approved SmPC
You may not be if
Patient previously treated with Cimzia. Patient with known hypersensitivity to any component of Cimzia
